Radio Frequency Identification (RFID) in Pharmaceuticals - Supply Chain Security Concerns Provide Impetus for RFID Adoption
Posted Apr 16 2010 1:16am
The leading business intelligence provider, has released its latest research, “Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline”, which provides an insight into the global biotechnology industry and analyzes the competitive positioning of the top 10 companies in the industry. This pharmaceutical and healthcare report estimates the market size of the global biotechnology industry and its future prospects. It benchmarks the leading companies in the biotechnology industry on selected parameters to analyze their competitive positioning in the market. The report analyzes the future landscape of the biotechnology industry by forecasting the revenues of leading companies to 2012. For each company the report analyzes the financial strength, product portfolio, pipeline strength and therapeutic focus of its R&D activities. It critically examines the strengths and weaknesses of individual companies and the opportunities and threats facing them.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
The report analyses the competitive landscape of the biotechnology industry, R&D strategies and pipeline of the top 10 players, and strengths, weaknesses, opportunities and threats facing these companies. Its scope includes - Market size of the global biotechnology industry and coverage of the changing competitive landscape from 2008 to 2012. - Review of key industry drivers and restraints which are likely to impact the global biotechnology industry in the future. - Analysis of the competitive positioning of the top 10 biotechnology companies globally. - Analysis of pipeline products in the global biotech market by therapy area like cancer, infectious diseases, respiratory disorders, autoimmune disorders, and product classes. - Financial analysis including annual revenues of top 10 companies from 2004 to 2008, with forecasts to 2012. - SWOT analysis, DuPont analysis and financial benchmarking of the top 10 biotech companies. - Analysis of the therapeutic focus, marketed products and product pipeline of top 10 biotech companies.